Literature DB >> 16963867

Case of anterior uveitis after intravitreal injection of bevacizumab.

Dante J Pieramici1, Robert L Avery, Alessandro A Castellarin, Ma'an A Nasir, Melvin Rabena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16963867     DOI： 10.1097/01.iae.0000234629.22614.cd

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  13 in total

Review 1.  [Intravitreal injection. Monitoring to avoid postoperative complications].

Authors:  C H Meyer; F Ziemssen; H Heimann
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

2.  Recurrence of acute anterior inflammation after intravitreal injection of bevacizumab in uveitis.

Authors:  Annabelle A Okada; Hiroshi Keino; Takayo Watanabe; Wakako Taki; Ruriko Hayakawa
Journal:  Jpn J Ophthalmol       Date:  2009-03-31       Impact factor: 2.447

3.  A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up.

Authors:  Federico Ricci; Antonio Calabrese; Cecilia De Felici; Filippo Missiroli; Marco Pileri; Federico Regine
Journal:  Digit J Ophthalmol       Date:  2016-05-16

4.  Intraocular inflammation following intravitreal injection of bevacizumab.

Authors:  Sophie J Bakri; Theresa A Larson; Albert O Edwards
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-17       Impact factor: 3.117

5.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

6.  [Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application].

Authors:  C H Meyer; S Mennel; N Eter
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

7.  Evaluating the safety of intracameral bevacizumab application using oxidative stress and apoptotic parameters in corneal tissue.

Authors:  Ali Akal; Turgay Ulas; Tugba Goncu; Muhammet Emin Guldur; Sezen Kocarslan; Abdullah Taskin; Hatice Sezen; Kudret Ozkan; Omer Faruk Yilmaz; Hakan Buyukhatipoglu
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

Review 8.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology.

Authors:  Jonathan A Micieli; Andrew Micieli
Journal:  Mcgill J Med       Date:  2011-06

10.  Drug-induced uveitis.

Authors:  Nikolas Js London; Sunir J Garg; Ramana S Moorthy; Emmett T Cunningham
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.